Physician profile
Eric Sako
NPI 1982022166
$1,412.65
in general payments reported to CMS, 2019-2025
17 companies · $27.30 in 2025
The $27.30 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $325 · 2021: $47.13 · 2022: $335 · 2023: $364 · 2024: $82.88 · 2025: $27.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $440.52 | 2019-2025 | Skyrizi |
| Genzyme Corporation | $347.68 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $115.20 | 2020-2023 | |
| Amgen INC. | $106.99 | 2020-2022 | |
| Janssen Biotech, INC. | $84.83 | 2022-2023 | Tremfya |
| Ucb, INC. | $48.92 | 2022-2024 | Bimzelx |
| Dermira, INC. | $48.66 | 2020 | |
| Lilly USA, LLC | $46.01 | 2020 | |
| Leo Pharma INC. | $27.38 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.10 | 2023 | Spevigo |
| Incyte Corporation | $21.58 | 2024 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $21.12 | 2022 | |
| Genentech USA, INC. | $18.76 | 2020 | |
| Almirall LLC | $18.57 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.90 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $12.94 | 2022 | |
| Polynovo North America LLC | $10.49 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Sako listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.